SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-000631
Filing Date
2021-04-29
Accepted
2021-04-29 16:06:28
Documents
1
Period of Report
2021-04-29

Document Format Files

Seq Description Document Type Size
1 kintara_fm4apr292021.html 4  
1 kintara_fm4apr292021.xml 4 8388
  Complete submission text file 0000905718-21-000631.txt   9899
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 100 SAN MATEO DR MENLO PARK CA 94025
Business Address
Brown Dennis M (Reporting) CIK: 0001569520 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 21870503